A new drug reduces risk of psychosis relapse in patients with dementia
Pimavanserin has not received approval from the FDA, but study results are encouraging
Psilocybin reduced depression symptoms as much as a leading antidepressant
New research compared the "magic mushrooms" component to Lexapro
Cocaine use slices and dices RNA in mouse brain cells
The analysis of epigenetic changes caused by cocaine use adds to the evidence that substance use disorders are rooted in biology
What nematodes laying eggs tells us about how cocaine affects the brain
New research uncovers a link between cocaine and acetylcholine that could eventually lead to new treatments for addiction
.jpg?auto=format&fit=max&w=3840 "A woman completes a purchase at a pharmacy")
Most patients prefer to access abortion medication from pharmacists instead of clinics
Medication abortion has been around for 20 years, and is a safe alternative to surgical abortion for many pregnant people
Could blockchain technology protect patients from counterfeit medication?
Not so fast. We should be wary of trying to science our way out of large-scale health issues
How seven cases of a mysterious opioid-induced disease revolutionized Parkinson's research
In the early 1980s, seven people took synthetic heroin. What happened next drastically changed our understanding of Parkinson's disease, and how to treat it
A new psychedelic drug gives psychiatric benefits without causing hallucinations
Research on ibogaine shows it is possible to engineer away side effects from beneficial psychoactives
Tweaked version of failed Alzheimer's disease drug restores memory in mice
The preliminary results suggest the drug may stop — and reverse — some Alzheimer's disease
Antidepressant drugs suppress important gut bacteria
This finding explains why some people who take antidepressants have unpleasant gut-centered side effects
A potential new treatment for premature aging diseases keeps stem cells fresh longer
The drug helps keep stem cells' telomeres long, preventing them from aging too quickly
The protein Klotho could extend the life of the brain. Is that a good thing?
Klotho originates in the brain but the hype has spread worldwide
Scientists identify a powerful anti-inflammatory compound in psychedelic drugs
The compound, called 2 C-H, reduces inflammation without mind-altering effects
Yeast could soon make psilocybin cheaper than their magic mushroom cousins can
New work could even lead to psychedelic intermediates not previously available in large quantities
"Inactive" ingredients in drugs could have toxic side effects
These compounds increase shelf life, but their safety hasn't been systematically tested
The two halves of a new compound team up to fight cancer
When combined, ruthenium and platinum do a better job at killing cancer cells than their individual parts
Drug repurposing gave remdesivir its second, third, and fourth chance
The antiviral has had a charmed life, failing multiple times but coming back again and again
Ice Bucket Challenge donations have helped fund promising ALS clinical trials, especially for "fast progressors"
There are currently only four drugs approved to help treat amyotrophic lateral sclerosis (ALS)
New types of drugs, called PROTACs, melt cancer-causing proteins away
Researchers from Yale and Oregon Health and Science universities have now used this approach to treat chronic myeloid leukemia cells